|
|
Volumn 12, Issue 3, 2016, Pages 270-272
|
|
Complete durable response from carboplatin and olaparib in a heavily pretreated triple-negative metastatic breast cancer with germline BRCA2 and "BRCAness" mutations
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BRCA2 PROTEIN;
CAPECITABINE;
CARBOPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
GEMCITABINE;
OLAPARIB;
PACLITAXEL;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
ANTINEOPLASTIC AGENT;
BRCA2 PROTEIN, HUMAN;
PHTHALAZINE DERIVATIVE;
PIPERAZINE DERIVATIVE;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BRAIN METASTASIS;
BREAST CARCINOMA;
BREAST METASTASIS;
CANCER COMBINATION CHEMOTHERAPY;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FEMALE;
GAMMA KNIFE RADIOSURGERY;
GASTROINTESTINAL SYMPTOM;
GENE MUTATION;
GENE OVEREXPRESSION;
GERMLINE MUTATION;
HUMAN;
LUNG METASTASIS;
LUNG NODULE;
MIDDLE AGED;
MONOTHERAPY;
MULTIPLE CYCLE TREATMENT;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PLEURA EFFUSION;
POSITRON EMISSION TOMOGRAPHY;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
TRIPLE NEGATIVE BREAST CANCER;
GENETICS;
TRIPLE NEGATIVE BREAST NEOPLASMS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BRCA2 PROTEIN;
CARBOPLATIN;
FEMALE;
GERM-LINE MUTATION;
HUMANS;
MIDDLE AGED;
PHTHALAZINES;
PIPERAZINES;
TREATMENT OUTCOME;
TRIPLE NEGATIVE BREAST NEOPLASMS;
|
|
EID: 84962591797
PISSN: 15547477
EISSN: 1935469X
Source Type: Journal
DOI: 10.1200/JOP.2016.010710 Document Type: Article |
|
Times cited : (6)
|
|
References (4)
|
